Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma
Authors:
- Yoshiki KajiwaraYKYoshiki Kajiwara
- Tadakazu AoTATadakazu Ao
- Satsuki MochizukiSMSatsuki Mochizuki
- Eiji ShintoESEiji Shinto
- Koichi OkamotoKOKoichi Okamoto
- Kazuo HaseKHKazuo Hase
- Hideki UenoHUHideki Ueno
- 1 October 2019
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 43 (10) , 1341-1348
Abstract
Colorectal liver metastasis (CRLM) is the most common pattern of metastases or recurrence in colorectal carcinoma; however, no robust pathologic prognostic factors have been identified. This study aimed to verify the prognostic value of poorly differentiated clusters (PDC) in liver metastatic lesions and to clarify the correlation between PDC in liver metastatic lesions (PDCliver) and the primary tumor histology. Consecutive patients who underwent resection for CRLM were pathologically reviewed. PDC was defined as cancer clusters comprising ≥5 cancer cells and lacking glandular formation and was quantifiably graded as G1 (liver was classified as G1, G2, and G3 for 68, 69, and 67 patients, respectively, and it was significantly associated with PDC grade in the primary tumor (Pliver significantly influenced overall survival (OS) after CRLM resection. According to the PDCliver grade, the 5-year OS rates were 68.9%, 48.3%, and 39.5% for G1, G2, and G3 (Pliver grade, tumor budding in the primary tumor, the number of liver metastasis and extrahepatic metastasis were independent prognostic factors. In conclusion, there is a correlation in the PDC grade between the primary tumor and liver metastatic lesion, and PDCliver grade could be a promising new prognostic factor after CRLM resection.Keywords
This publication has 36 references indexed in Scilit:
- RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2013
- Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional gradingVirchows Archiv, 2012
- Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon CancerJournal of Clinical Oncology, 2011
- Expression of L1 Cell Adhesion Molecule and Morphologic Features at the Invasive Front of Colorectal CancerAmerican Journal of Clinical Pathology, 2011
- Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherinBritish Journal of Cancer, 2011
- Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal CancerJournal of Clinical Oncology, 2011
- Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases?Annals of Surgery, 2010
- A New Prognostic Staging System for Rectal CancerAnnals of Surgery, 2004
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver MetastasesAnnals of Surgery, 2004
- Prognostic value of tumor “budding” in patients with colorectal cancerDiseases of the Colon & Rectum, 1993